These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38001941)

  • 21. A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.
    Klink B; Miletic H; Stieber D; Huszthy PC; Campos Valenzuela JA; Balss J; Wang J; Schubert M; Sakariassen PØ; Sundstrøm T; Torsvik A; Aarhus M; Mahesparan R; von Deimling A; Kaderali L; Niclou SP; Schröck E; Bjerkvig R; Nigro JM
    PLoS One; 2013; 8(3):e59773. PubMed ID: 23527265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligodendroglioma cells synthesize the differentiation-specific linker histone H1˚ and release it into the extracellular environment through shed vesicles.
    Schiera G; Di Liegro CM; Saladino P; Pitti R; Savettieri G; Proia P; Di Liegro I
    Int J Oncol; 2013 Dec; 43(6):1771-6. PubMed ID: 24085372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma.
    Favaro R; Appolloni I; Pellegatta S; Sanga AB; Pagella P; Gambini E; Pisati F; Ottolenghi S; Foti M; Finocchiaro G; Malatesta P; Nicolis SK
    Cancer Res; 2014 Mar; 74(6):1833-44. PubMed ID: 24599129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
    Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG
    BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.
    Qi L; Wang ZY; Shao XR; Li M; Chen SN; Liu XQ; Yan S; Zhang B; Zhang XD; Li X; Zhao W; Pan JA; Zhao B; Zhang XD
    Oncogene; 2020 Sep; 39(37):5964-5978. PubMed ID: 32753650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian Clock in a Mouse Colon Tumor Regulates Intracellular Iron Levels to Promote Tumor Progression.
    Okazaki F; Matsunaga N; Okazaki H; Azuma H; Hamamura K; Tsuruta A; Tsurudome Y; Ogino T; Hara Y; Suzuki T; Hyodo K; Ishihara H; Kikuchi H; To H; Aramaki H; Koyanagi S; Ohdo S
    J Biol Chem; 2016 Mar; 291(13):7017-28. PubMed ID: 26797126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Inflammatory Changes Associated with Canine Oligodendroglioma.
    Sloma EA; Creneti CT; Erb HN; Miller AD
    J Comp Pathol; 2015; 153(2-3):92-100. PubMed ID: 26145723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioblastoma with oligodendroglial components: glioblastoma or anaplastic oligodendroglial tumors.
    Takeuchi H; Hosoda T; Kitai R; Kodera T; Arishima H; Tsunetoshi K; Neishi H; Yamauchi T; Sato K; Imamura Y; Itoh H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2012 Jul; 29(3):154-9. PubMed ID: 22527749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature.
    Kan P; Gottfried O; Blumenthal DT; Townsend JJ; Drozd-Borysiuk E; Brothman AR; Jensen RL
    J Neurosurg; 2004 Apr; 100(4):700-5. PubMed ID: 15070126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetic study of a metastatic oligodendroglioma.
    Giordana MT; Ghimenti C; Leonardo E; Balteri I; Iudicello M; Duò D
    J Neurooncol; 2004 Feb; 66(3):265-71. PubMed ID: 15015656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEAT1 Is a Novel Oncogenic LncRNA and Correlated with miR-143 in Pediatric Oligodendrogliomas.
    Ak Aksoy S; Mutlu M; Balcin RN; Taskapilioglu MO; Tekin C; Kaya S; Civan MN; Kocaeli H; Bekar A; Eser Ocak P; Cecener G; Egeli U; Tolunay S; Tunca B
    Pediatr Neurosurg; 2021; 56(2):133-139. PubMed ID: 33744906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification of oligodendroglial tumors based on histopathology criteria is a significant predictor of survival--clinical, radiological and pathologic long-term follow-up analysis.
    Sepulveda Sanchez JM; Martinez Montero JC; Diez-Lobato R; Hernandez-Lain A; Cabello A; Ramos A; Gonzalez Leon P; Ricoy Campo JR
    Clin Neuropathol; 2009; 28(1):11-20. PubMed ID: 19216215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Well-differentiated pediatric glial neoplasms with features of oligodendroglioma, angiocentric glioma and dysembryoplastic neuroepithelial tumors: a morphological diagnostic challenge.
    Keser H; Barnes M; Moes G; Lee HS; Tıhan T
    Turk Patoloji Derg; 2014; 30(1):23-9. PubMed ID: 24448703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-cause and tumor-specific mortality trends in geriatric oligodendroglioma (OG) patients: A surveillance, epidemiology, and end results (SEER) analysis.
    Furst T; Hoffman H; Chin LS
    J Clin Neurosci; 2020 Mar; 73():94-100. PubMed ID: 31952972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas.
    Fu W; Wang W; Li H; Jiao Y; Weng J; Huo R; Yan Z; Wang J; Xu H; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Oncol; 2020; 10():78. PubMed ID: 32117733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
    Deininger MH; Weller M; Streffer J; Meyermann R
    Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of Oligodendroglioma Patients Stratified by Age: A SEER Population-Based Analysis.
    Jin K; Zhang SY; Li LW; Zou YF; Wu B; Xia L; Sun CX
    Int J Gen Med; 2021; 14():9523-9536. PubMed ID: 34916834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells.
    Long PM; Tighe SW; Driscoll HE; Moffett JR; Namboodiri AM; Viapiano MS; Lawler SE; Jaworski DM
    PLoS One; 2013; 8(11):e80714. PubMed ID: 24278309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.
    Rychtarcikova Z; Lettlova S; Tomkova V; Korenkova V; Langerova L; Simonova E; Zjablovskaja P; Alberich-Jorda M; Neuzil J; Truksa J
    Oncotarget; 2017 Jan; 8(4):6376-6398. PubMed ID: 28031527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.